Acme is not as recognizable as the rest of the names, but this is precisely why investors are offered this company at a discount. Many would argue that because the company is small, its riskiness is higher than the companies above. While that may be true to some extent (for example, three customers each exceed 10% of Acme's sales), the upside is also higher as the company has room to grow. Acme has an on-going goal of generating 30% of its sales from products developed in the last 3 years. This is something that the large companies listed above would have great difficulty achieving.
About the author:
This article was republished and written by Nurseb911 at Triaging My Way To Financial Success. This site provides content on value and dividend investing while maintaining a focus on fundamental and security analysis for both new and established investors. You may email questions and comments to the author at nurseb911 [AT] gmail.com